Recombinant CIRP could induce inflammatory responses in vivo and in vitro, and neutralization of CIRP could attenuate sepsis during fluid resuscitation in hemorrhaged rats (12), indicating that eCIRP might be a potential target for ALI/ARDS therapy. This evidence concerns the gene CIRBP and acute respiratory distress syndrome.